Advancing Global Health Equity: Enhancing Clinical Trials Access and Cooperation to Save Millions of Lives from Cancer

Nov 08, 2023
  • Description

Cancer is a leading cause of death worldwide, accounting for approximately 10 million deaths every year. Many cancer deaths are preventable if the disease is detected early and treated effectively. Clinical trials represent the critical step in translating scientific discoveries into lifesaving for patients with cancer. However, access to clinical trials is limited to fewer than 5% of patients globally, with significant disparities among diverse communities.

This report finds that if China were to join the U.S.-led cancer research project Cancer Moonshot and its core initiative Project Orbis, could significantly increase the estimated number of new cancer cases represented amongst its members to approximately 46.88%. Furthermore, it could greatly streamline international regulatory processes and bolster global health equity by expanding access to clinical trials and precision oncology worldwide and the time needed to roll out new cancer treatments globally would significantly shorten, potentially turning a 10-15-year process into a 2-3-year process.